Michael P. Collins

2.8k citations
52 papers · 1.7k indexed · h-index 23

Michael P. Collins

48 papers receiving 1.7k citations

Peers

Michael P. Collins
Comparison fields: 5 of 136
  • Rheumatology 272
  • Hepatology 124
  • Cancer Research 216
  • Pulmonary and Respiratory Medicine 423
  • Immunology and Allergy 78
Replace Masaru Takenaka with:
Masaru Takenaka Japan
Young H. Kim United States
Shinichi Sakamoto Japan
Raphaël Saffroy France
Otto Dietze Austria
Csaba Szalai Hungary
Eric A. Van Marck Belgium
G. Zajicek Israel
Koji Harada Japan
James M. Slater United States
Michael P. Collins relative to Masaru Takenaka Japan Masaru Takenaka's profile →
Citations per field
00.5×3.4×
Masaru Takenaka · 1×
Citations per year

Countries citing papers authored by Michael P. Collins

Since Specialization
Citations

This map shows the geographic impact of Michael P. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Collins more than expected).

Fields of papers citing papers by Michael P. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Collins. The network helps show where Michael P. Collins may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael P. Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael P. Collins Line = papers co-authored together Michael P. Collins links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20241
4 20223
5 20215
6 202021
7 2020121
8 201921
9 201314
10 201048
11 2010154
12 2010116
13 200945
14 200823
15 200641
16 2006327
17 200314
18 199929
19 199835
20 199830

About Michael P. Collins

Michael P. Collins is a scholar working on Hepatology, Health and Cancer Research, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include ATP Synthase and ATPases Research (6 papers), Renal cell carcinoma treatment (5 papers), Mitochondrial Function and Pathology (4 papers), Hepatitis B Virus Studies (4 papers), Cancer Genomics and Diagnostics (4 papers), Renal and related cancers (4 papers), RNA modifications and cancer (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). The work is most often cited by research in Rheumatology (272 citations), Hepatology (124 citations) and Cancer Research (216 citations). Michael P. Collins has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Michael Forgac, Nigel Paneth, Sabina Signoretti, John M. Lorenz, Bridget K. Buckmeier, James Jetton, J P Kushner, A. H. Filipovich, Michael B. Rothenberg and Joyce Villanueva. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Applied Physics Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026